Clinical trial
Transgender and GENdEr diverSe Individuals Screening for Breast Cancer: the GENESIS Study
NCT06347393 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transgender and GENdEr diverSe Individuals Screening for Breast Cancer: the GENESIS Study
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 1, 2024
- Completion date
- March 31, 2026
- Enrollment
- 1,600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer